aspirin + desmopressin

Aspirin + desmopressin is a combination of two drugs with distinct mechanisms of action. Aspirin (acetylsalicylic acid) is a nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase enzymes, leading to decreased synthesis of thromboxane A2 and thus inhibiting platelet aggregation. Desmopressin is a synthetic analogue of vasopressin that increases plasma levels of coagulation factor VIII and von Willebrand factor, enhancing platelet function and promoting hemostasis. This combination may be considered in clinical scenarios where aspirin-induced bleeding risk needs to be mitigated by the pro-hemostatic effects of desmopressin, such as perioperative management or acute bleeding events in patients on aspirin therapy[2][3][4][6]. The use should be carefully monitored due to potential interactions and increased risk or severity of adverse effects[1][5][7].